Infusion pump market to reach $25.01B by 2030

The infusion pump market is projected to grow from $17.2 billion in 2026 to $25.01 billion by 2030, driven by chronic disease prevalence, home infusion demand and smarter hospital systems. North America led the market in 2025, while connected devices and dose-error reduction systems are shaping the next phase of growth.

Why it matters: - Infusion pumps are central to controlled delivery of medications and nutrients in hospitals, home care and chronic disease management. - The market’s growth reflects rising demand for precise dosing, patient safety and connected care infrastructure. - The expansion also points to broader adoption of smart hospital technology and home-based treatment models.

What happened: - The Business Research Company released an infusion pump market report on Aug. 12, 2026. - The report estimates the market will rise from $15.73 billion in 2025 to $17.2 billion in 2026, a 9.3% compound annual growth rate. - The market is forecast to reach $25.01 billion by 2030, at a 9.8% compound annual growth rate. - The report includes a free sample and the full market report.

The details: - Market growth in the recent period was driven by more hospital admissions requiring infusion therapy. - Broader use of intravenous medication delivery also supported demand. - Oncology and critical care treatment expansion added to market growth. - Programmable infusion devices and medication safety protocols contributed to adoption. - The report says future growth will come from home infusion therapy, connected healthcare technologies, chronic disease management programs, hospital system integration and smart hospital investment. - Key trends include smart infusion pumps, ambulatory and home-based infusion devices, dose error reduction systems, wireless connectivity and a focus on patient safety and dosing accuracy. - An infusion pump is a medical device that delivers fluids such as medications or nutrients directly into a patient’s bloodstream in a controlled, precise manner. - The device regulates flow rate and volume to improve accuracy in treatment. - Chronic disease prevalence is a major driver of demand. - Cancer and diabetes are among the conditions increasing the need for infusion therapy. - In January 2023, the National Center for Biotechnology Information said the number of people living with chronic diseases worldwide is expected to grow from 71.522 million in 2020 to 142.66 million by 2050. - The International Diabetes Federation projects the global diabetic population will reach 643 million by 2030 and 783 million by 2045. - North America held the largest share of the infusion pump market in 2025. - The report also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The report’s growth outlook suggests infusion pumps are moving from a hospital hardware category toward a more connected care platform. - Stronger interest in home infusion and wireless integration signals pressure to shift treatment outside traditional inpatient settings. - The chronic disease data underscores why infusion technology remains tied to long-term care demand rather than one-time procedures.

What's next: - The Business Research Company says its 2026 reports add market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards and market hotspot infographics. - The company also plans deeper analysis of key technologies and future trends. - Regional growth patterns across the covered markets will remain a key focus as adoption broadens beyond North America.

The bottom line: - Infusion pump demand is set to keep rising as chronic disease burdens grow and hospitals push toward smarter, safer and more connected delivery systems.